Published on: 2025-06-10 04:33:33 Source: POL (ex-MATIC) Author: Events & Conferences
The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepb... Stay informed with the latest.